A Landscape of Artificial Intelligence (AI) In Pharmaceutical R&D

Where you find opportunities to grow

* Can't find your brand, product, service? Join BPT Marketplace

Biopharma news


Vaccine Nationalism, CDMO expansion, AMR and Dual sourcing predicted in 2021 According to New CPhI Report

   by Abdul Khalifeh    24
Vaccine Nationalism, CDMO expansion, AMR and Dual sourcing predicted in 2021 According to New CPhI Report

A new report from CPhI explores the potential implications in 2021 of impending vaccine approvals, a new administration in the White House and a return to dual supply chain strategies.

The report – which summarises expert analysis into 12 key findings – foresees a particularly positive outlook for the pharma manufacturing supply chain, as a result of the demand for increased second source contingencies, alongside the huge scale-up of vaccine capacity currently underway. A consequence of which is likely to encourage expansion across the contract services sector for all product classes and therapy areas.

SEPHA INTRODUCES NEWLY PATENTED 3D LEAK DETECTION TECHNOLOGY FOR BLISTER PACKS

   by Lucy Shaw    26
SEPHA INTRODUCES NEWLY PATENTED 3D LEAK DETECTION TECHNOLOGY FOR BLISTER PACKS

Belfast, UK, November 30, 2020: Sepha, a specialist in leak test solutions for the pharmaceutical packaging industry, will be introducing its newly patented 3D Leak Detection technology for pharmaceutical blister packs via two live online webinars on the 2nd and 3rd December 2020. Aimed at pharmaceutical manufacturers, the new technology incorporates a 3D sensor to provide volumetric measurement to assess the integrity of a range of pharmaceutical solid dose and flexible barrier packaging.

MOBILion and International Research Team are Awarded Grant from The Michael J. Fox Foundation

   by Lucy Shaw    108
MOBILion and International Research Team are Awarded Grant from The Michael J. Fox Foundation

MOBILion Systems, Inc., a pioneer in fast, efficient, high-resolution instrumentation for biomarker discovery, diagnostics and therapeutic development, is collaborating with an international research team to identify alterations in the metabolism of selective glycosphingolipids in specific brain regions that contribute to the early onset and progression of Parkinson’s disease.